Monday, December 22, 2025 | 11:35 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Deepak Korgaonkar

Deepak Korgaonkar

Page 88 - Deepak Korgaonkar/workspace/business Standard Web/undefined

Midcap index nears record high; Varun Beverages, Cummins climb new peaks

The midcap index hit an intra-day high of 26,705.56, was less than 2% away from its record high level of 27,246.34, touched on October 19, 2021.

Midcap index nears record high; Varun Beverages, Cummins climb new peaks
Updated On : 26 May 2023 | 11:22 AM IST

Weak Q4 performance drags Page Industries to 19-month low; stock sinks 15%

The company said it experienced some impact on profitability due to higher inventory levels acquired during an inflationary period and lower than optimal capacity utilization.

Weak Q4 performance drags Page Industries to 19-month low; stock sinks 15%
Updated On : 26 May 2023 | 10:52 AM IST

Ceat hits new summit; zooms over 46% so far this May on strong Q4 results

The management is hopeful that the coming quarters will see further uptick in growth, as commodity prices remain stable, and the global inflation slows down.

Ceat hits new summit; zooms over 46% so far this May on strong Q4 results
Updated On : 24 May 2023 | 10:42 AM IST

IndusInd Bank gains 15% in one month; nears 52-week high on healthy outlook

The management introduced planning cycle - 6 (FY23-26) wherein they have guided for 18-23% YoY credit growth, mainly-driven by retail (55-60% proportion) and PPOP margins to be 5.25-5.75%.

IndusInd Bank gains 15% in one month; nears 52-week high on healthy outlook
Updated On : 23 May 2023 | 11:21 AM IST

Adani Group shares trade mixed post Supreme Court panel report

An expert committee constituted by India's Supreme Court to investigate the Adani Group said it was not possible to conclude if there has been regulatory failure regarding price manipulations.

Adani Group shares trade mixed post Supreme Court panel report
Updated On : 19 May 2023 | 1:39 PM IST

Gland Pharma tanks 20%, hits record low on weak Q4 results

Revenue declined 29% YoY due to lower offtake of the key products in developed as well as domestic markets and due to Production line shut down in Pashamylaram Penems facility due to line upgradation.

Gland Pharma tanks 20%, hits record low on weak Q4 results
Updated On : 19 May 2023 | 10:17 AM IST

ITC slips 4% in 2 days post Q4 results but analysts remain bullish on stock

Thus far in the calendar year 2023, the stock has outperformed the market by surging 25 per cent, as compared to 0.55 per cent gain in the S&P BSE Sensex.

ITC slips 4% in 2 days post Q4 results but analysts remain bullish on stock
Updated On : 19 May 2023 | 9:37 AM IST

Stock of this capital goods company has zoomed over 100% since April

The Finance Minister's latest Budget for FY 2023-24 has laid emphasis on government commitment to move towards net zero carbon emission by 2070

Stock of this capital goods company has zoomed over 100% since April
Updated On : 18 May 2023 | 11:32 AM IST

BSE Midcap index hits 52-week high; Astral surges 9% on strong Q4 results

Despite global concerns, the domestic market structure remains positive on the back of healthy macro data, strong earnings, and recent FIIs buying, brokerage firm Motilal Oswal said in a note.

BSE Midcap index hits 52-week high; Astral surges 9% on strong Q4 results
Updated On : 16 May 2023 | 11:11 AM IST

Dr Reddy's Laboratories QoQ showing catches a cold on weak US sales

While pharma major has maintained its margin guidance, expensive valuations limit upside

Dr Reddy's Laboratories QoQ showing catches a cold on weak US sales
Updated On : 11 May 2023 | 6:57 PM IST

Varun Beverages joins Rs 1 trillion m-cap club; zooms 108% in 11 months

At 10:43 AM; with a market cap of Rs 1.02 trillion, VBL claimed the 48th spot in the overall market cap ranking, the BSE data shows.

Varun Beverages joins Rs 1 trillion m-cap club; zooms 108% in 11 months
Updated On : 10 May 2023 | 11:07 AM IST

Mankind Pharma lists at 20% premium; should you buy, sell, or hold?

Shares of Mankind listed at Rs 1,300, a 20 per cent premium over its issue price of Rs 1,080 on the National Stock Exchange (NSE) and the BSE

Mankind Pharma lists at 20% premium; should you buy, sell, or hold?
Updated On : 10 May 2023 | 6:34 AM IST

ABB India hits new high on strong Q1 results; stock up 33% so far in 2023

ABB's order inflows came at Rs 3,125 crore, up 36.4 per cent year-on-year (YoY) with order backlog of Rs 7,170 crore, which was up by 37.1 per cent, YoY.

ABB India hits new high on strong Q1 results; stock up 33% so far in 2023
Updated On : 04 May 2023 | 10:13 AM IST

PI Industries derisks biz with lucrative pharma buys; stock up 10.2%

Brokerages have upgraded estimates for firm, expect return ratios to improve

PI Industries derisks biz with lucrative pharma buys; stock up 10.2%
Updated On : 28 Apr 2023 | 10:25 AM IST

ITC extends rally, hits new high; surges 25% so far in calendar year 2023

Thus far in calendar year 2023, ITC surpassed Infosys, HDFC, SBI, Bharti Airtel, Adani Enterprises and Life Insurance Corporation of India (LIC) in market-cap ranking.

ITC extends rally, hits new high; surges 25% so far in calendar year 2023
Updated On : 27 Apr 2023 | 11:24 AM IST

New dividend, bonus share policy to create value for Gujarat PSUs: Analysts

Analysts believe the move will create shareholder value

New dividend, bonus share policy to create value for Gujarat PSUs: Analysts
Updated On : 26 Apr 2023 | 9:38 AM IST

Ipca Labs dips 9%, hits 52-wk low on plan to buy 33.4% stake in Unichem Lab

Brokerages believe the acquisition is expensive, given increased competition in the US generics oral solids space, rising regulatory risks and strong efforts needed to turnaround Unichem Labs

Ipca Labs dips 9%, hits 52-wk low on plan to buy 33.4% stake in Unichem Lab
Updated On : 25 Apr 2023 | 11:09 AM IST

RBI order insures gains for HDFC Life stock; analysts see up to 83% upside

RBI's permission to increase stake in subsidiaries puts an end to the overhang on the stock, said Motilal Oswal in a note

RBI order insures gains for HDFC Life stock; analysts see up to 83% upside
Updated On : 24 Apr 2023 | 10:07 PM IST

Sun Pharma's Mohali facility to pause supplies to the US; stock dips 3%

Although the overall impact could be minimal (being an OSD facility), this may lead to stricter scrutiny for other plants, said ICICI Securities in a note.

Sun Pharma's Mohali facility to pause supplies to the US; stock dips 3%
Updated On : 24 Apr 2023 | 11:11 AM IST

ITC surpasses HDFC's m-cap to become 7th most valued listed company

Thus far in calendar year 2023 (CY23), ITC has surged 22%, as compared to 3% decline in the S&P BSE Sensex, and 2.4% rise in HDFC Ltd

ITC surpasses HDFC's m-cap to become 7th most valued listed company
Updated On : 21 Apr 2023 | 1:36 PM IST